Transforming COPD management: the role of dupilumab
- PMID: 40651491
- DOI: 10.1016/S2213-2600(25)00082-7
Transforming COPD management: the role of dupilumab
Conflict of interest statement
YÇ is funded by the Copenhagen University Hospital—Herlev and Gentofte. YÇ reports personal fees from AstraZeneca, Boehringer-Ingelheim, Chiesi, and GlaxoSmithKline; and grants, personal fees, and travel expenses from Sanofi, outside of the submitted work. YÇ has participated on an Advisory Board for GlaxoSmithKline.
LinkOut - more resources
Full Text Sources